265 related articles for article (PubMed ID: 31479998)
1. Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
Gong LL; Yang S; Zhang W; Han FF; Lv YL; Xuan LL; Liu H; Liu LH
J Pharm Biomed Anal; 2020 Jan; 177():112848. PubMed ID: 31479998
[TBL] [Abstract][Full Text] [Related]
2. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
[TBL] [Abstract][Full Text] [Related]
3. Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS.
Gong LL; Yang S; Zhang W; Han FF; Xuan LL; Lv YL; Liu H; Liu LH
Dis Markers; 2020; 2020():8842320. PubMed ID: 32733621
[TBL] [Abstract][Full Text] [Related]
4. Exploratory lipidomics in patients with nascent Metabolic Syndrome.
Ramakrishanan N; Denna T; Devaraj S; Adams-Huet B; Jialal I
J Diabetes Complications; 2018 Aug; 32(8):791-794. PubMed ID: 29895440
[TBL] [Abstract][Full Text] [Related]
5. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
6. Regulation of endogenic metabolites by rosuvastatin in hyperlipidemia patients: An integration of metabolomics and lipidomics.
Lee H; Choi JM; Cho JY; Kim TE; Lee HJ; Jung BH
Chem Phys Lipids; 2018 Aug; 214():69-83. PubMed ID: 29852124
[TBL] [Abstract][Full Text] [Related]
7. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS.
Liu X; Gao X; Zhang R; Liu Z; Shen N; Di Y; Fang T; Li H; Tian F
Clin Biochem; 2020 Aug; 82():40-50. PubMed ID: 32194037
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A and D Absorption in Adults with Metabolic Syndrome versus Healthy Controls: A Pilot Study Utilizing Targeted and Untargeted LC-MS Lipidomics.
Chatelaine H; Dey P; Mo X; Mah E; Bruno RS; Kopec RE
Mol Nutr Food Res; 2021 Jan; 65(2):e2000413. PubMed ID: 33167078
[TBL] [Abstract][Full Text] [Related]
9. Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals.
Olund Villumsen S; Benfeitas R; Knudsen AD; Gelpi M; Høgh J; Thomsen MT; Murray D; Ullum H; Neogi U; Nielsen SD
Front Immunol; 2021; 12():742736. PubMed ID: 35095835
[TBL] [Abstract][Full Text] [Related]
10. Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants.
Wu Q; Li J; Sun X; He D; Cheng Z; Li J; Zhang X; Xie Y; Zhu Y; Lai M
EBioMedicine; 2021 Dec; 74():103707. PubMed ID: 34801968
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease.
Surowiec I; Noordam R; Bennett K; Beekman M; Slagboom PE; Lundstedt T; van Heemst D
Metabolomics; 2019 Feb; 15(2):23. PubMed ID: 30830468
[TBL] [Abstract][Full Text] [Related]
12. Untargeted lipidomics reveals specific lipid abnormalities in Sjögren's syndrome.
Lu J; Guo Y; Lu Y; Ji W; Lin L; Qian W; Chen W; Wang J; Lv X; Ke M; Kong D; Shen Q; Zhu Y; Liu P; Su J; Wang L; Li Y; Gao P; Shan J; Liu S
Rheumatology (Oxford); 2021 Mar; 60(3):1252-1259. PubMed ID: 32911538
[TBL] [Abstract][Full Text] [Related]
13. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
[TBL] [Abstract][Full Text] [Related]
14. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
15. Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome.
Mohamed A; Collins J; Jiang H; Molendijk J; Stoll T; Torta F; Wenk MR; Bird RJ; Marlton P; Mollee P; Markey KA; Hill MM
PLoS One; 2020; 15(1):e0227455. PubMed ID: 31914155
[TBL] [Abstract][Full Text] [Related]
16. Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.
Jing Z; Liu L; Shi Y; Du Q; Zhang D; Zuo L; Du S; Sun Z; Zhang X
Front Endocrinol (Lausanne); 2021; 12():692893. PubMed ID: 34630321
[TBL] [Abstract][Full Text] [Related]
17. UHPLC Q-Exactive MS-based spleen metabolomics and lipidomics to explore the effect mechanisms of Danggui Buxue Decoction in anemia mice.
Liu Y; Li X; Li A; Li K; Qin X
J Pharm Biomed Anal; 2020 Jun; 185():113234. PubMed ID: 32171146
[TBL] [Abstract][Full Text] [Related]
18. Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma.
Khan MJ; Codreanu SG; Goyal S; Wages PA; Gorti SKK; Pearson MJ; Uribe I; Sherrod SD; McLean JA; Porter NA; Robinson RAS
Rapid Commun Mass Spectrom; 2020 Nov; 34(22):e8911. PubMed ID: 32738001
[TBL] [Abstract][Full Text] [Related]
19. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
20. Integrating machine learning and nontargeted plasma lipidomics to explore lipid characteristics of premetabolic syndrome and metabolic syndrome.
Huang X; He Q; Hu H; Shi H; Zhang X; Xu Y
Front Endocrinol (Lausanne); 2024; 15():1335269. PubMed ID: 38559697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
